Cogent stockholders approve officer exculpation; annual meeting results filed

Cogent Biosciences, Inc.

Approved amendment to certificate of incorporation to exculpate officers: 86,181,373 for, 4,422,462 against.
Re-elected directors Karen Ferrante (68,418,781 for) and Matthew E. Ros (77,274,345 for).
Ratified PricewaterhouseCoopers as auditor with 101,115,649 votes for.
Advisory vote on executive compensation approved: 89,797,699 for, 808,715 against.
Company presenting at Jefferies Global Healthcare Conference on June 5, 2025 (details in corporate presentation).

item 5.03item 5.07item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.